Multi-field Functional Electrical Stimulation for Distal Upper-limb Rehabilitation After Subacute Stroke: a Pilot Randomised Controlled Trial (PI52021Rehab)

The purpose of this study is to evaluate the feasibility, usability, and safety of multi-field FES-assisted therapy for hand rehabilitation in individuals with subacute stroke. A secondary, exploratory objective is to estimate preliminary effect sizes for distal upper-limb motor outcomes to inform the design of future adequately powered trials.

Fesia Grasp rehabilitation will be compared with usual care rehabilitation of upper limb.

  • Experimental group: patients will receive Fesia Grasp therapy (intensive, repetitive and functional exercises assisted by functional electrical stimulation)
  • Control group - patients will receive standard care.

Study Overview

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Córdoba
      • Córdoba, Córdoba, Spain, 14004
        • Hospital Universitario Reina Sofía

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 18 years old or older subjects with hemiparesis in the upper limb after stroke, which have been referred to the Rehabilitation Unit of the Reina University Hospital.
  • Unilateral paresis
  • Cognitive ability to assimilate and actively participate in the protocol of evaluation and treatment

Exclusion Criteria:

  • Very severe proximal spasticity: Ashworth > 3.
  • Psychiatric illness (including post-stroke depression).
  • Cognitive impairment.
  • Inability to provide informed consent.
  • Other severe medical problems.
  • Severe hemi-spatial neglect or anosognosia involving the affected arm.
  • Pacemakers
  • Pregnant women.
  • Skin ulcers.
  • Peripheral neuropathies.
  • Edema of the affected forearm and / or hand.
  • Severe pain.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard Therapy
Physical therapy applied to the subject. Duration: 80 min twice a week, for 6 weeks.
Experimental: Functional Electrical Stimulation

The patient will receive a therapy with functional electrical stimulation. For this, a device called "Fesia Grasp" will be used.

Duration: 80 min twice a week, for 6 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Usability questionnaire specifically designed for this study
Time Frame: 6 weeks
It consists of a 5 item questionnaire with five response options (Likert sacle); from Strongly agree to Strongly disagree. To evaluate the satisfaction of patients with the system and the therapy.
6 weeks
Intrinsic Motivation Inventory (IMI)
Time Frame: 6 weeks
This scale is a multidimensional scale intended to assess participants subjective experience with the device (interest/enjoyment, perceived competence, effort, value/usefulness, felt pressure and tension, and perceived choice while performing a given activity). Consist of 20 item questionnaire with answers from 1 'strongly agree' to 7 'strongly disagree'
6 weeks
Adverse events
Time Frame: 6 weeks
Any untoward medical occurrence during the clinical trial
6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified Ashworth Scale (MAS)
Time Frame: Baseline; 6 weeks; 3 months
This scale measures resistance during passive soft-tissue stretching and is used as a simple measure of spasticity. It is single-item measures ranging from 0 to 4, where 0 indicates no increase in muscle tone and 4 indicates that the affected part is rigid in flexion or extension.
Baseline; 6 weeks; 3 months
Box & Blocks Test
Time Frame: Baseline; 6 weeks; 3 months

It assesses unilateral gross manual dexterity. Individuals are seated at a table, facing a rectangular box that is divided into two square compartments of equal dimension by means of a partition. One hundred and fifty, 2.5 cm, colored, wooden cubes or blocks are placed in one compartment or the other.

The test is scored by counting the number of blocks carried over the partition from one compartment to the other during the one-minute trial period.

Baseline; 6 weeks; 3 months
Motor Activity Log (MAL)
Time Frame: Baseline; 6 weeks; 3 months
Semi-structured interview to assess arm function. Individuals are asked to rate Quality of Movement and Amount of Movement during 30 daily functional tasks. Target tasks include object manipulation (e.g. pen, fork, comb, and cup) as well as the use of the arm during gross motor activities (e.g. transferring to a car, steadying oneself during standing, pulling a chair into a table while sitting).
Baseline; 6 weeks; 3 months
Fugl-Meyer Assessment (FMA) scale
Time Frame: 6 weeks
It is an index to assess the sensorimotor impairment in individuals who have had stroke. The Fugl-Meyer Assessment scale is an ordinal scale that has 3 points for each item. A zero score is given for the item if the subject cannot do the task. A score of 1 is given when the task is performed partially and a score of 2 is given when the task is performed fully. The maximun score is 66 points
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Fernando Mayordomo Riera, MD, Hospital General Universitario Reina Sofía de Murcia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 14, 2022

Primary Completion (Actual)

August 1, 2023

Study Completion (Actual)

December 1, 2023

Study Registration Dates

First Submitted

July 16, 2021

First Submitted That Met QC Criteria

August 4, 2021

First Posted (Actual)

August 5, 2021

Study Record Updates

Last Update Posted (Actual)

May 27, 2026

Last Update Submitted That Met QC Criteria

May 22, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The results will be available for other investigators.

IPD Sharing Time Frame

Once the trial is ended and the result are published in a paper.

IPD Sharing Access Criteria

Upon request to silvia.guillen@imibic.org

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Functional electrical stimulation through medical device

Subscribe